The authors reply

New England Journal of Medicine

Volumn 371, Issue 11, 2014, Pages 1077-

  Kourtis, Athena P ^a   Read, Jennifer S ^b   Jamieson, Denise J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ATTRIBUTABLE RISK; CHEMOTHERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION SENSITIVITY; LETTER; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; PYELONEPHRITIS; RISK ASSESSMENT; TUBERCULOSIS; UNITED KINGDOM; URINARY TRACT INFECTION; COMMUNICABLE DISEASE; FEMALE; NOTE; PREGNANCY COMPLICATION; SEVERITY OF ILLNESS INDEX;

COMMUNICABLE DISEASES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEVERITY OF ILLNESS INDEX;

EID: 84908233992     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1408436     Document Type: Letter

References (2)

1. Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol 2013; 2013: 752852.
2. Zenner D, Kruijshaar ME, Andrews N, et al. Pregnancy: a risk for developing tuberculosis? A national cohort and selfcontrolled case series study using UK primary care data abstract. Amsterdam: European Respiratory Society, 2011.